Future Path Medical Holding Company, LLC

CONCORD, OH · Founded 2008 · CIK 0001569602 · Biotech

Pathogen-free genetically modified pigs for xenotransplantation

future.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$2.6M
5 Form D · Dec 2014
142 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$497,000
Private capital raisedForm D · SEC$1,080,001
Private capital raisedForm D · SEC$1,533,335
Private capital raised· 1 of 2 same dayForm D · SEC$1,466,668
Private capital raised· 2 of 2 same dayForm D · SEC$976,091
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1805F.D.G. MINING INC.—$50K
1806Andon Bio Inc.—$250K
1807Chia Inc.—$28M
1808Future Path Medical Holding Company, LLC—$2.6M
1809ImmunityBio, Inc.—$633M
1810MODERN MEADOW—$53M
1811Sapience Therapeutics Inc.—$8.3M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Anthony BoiarskiExecutive Officer
  • Peter BrumbergsExecutive Officer
  • V BryantExecutive Officer
  • Brian GilbertExecutive Officer
  • Delmar MolherExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.